{"id":21913,"date":"2021-10-01T08:28:24","date_gmt":"2021-10-01T12:28:24","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=21913"},"modified":"2021-10-01T08:28:24","modified_gmt":"2021-10-01T12:28:24","slug":"pipeline-update-get-in-shape-fitness-companies-set-terms-for-ipo","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-get-in-shape-fitness-companies-set-terms-for-ipo\/","title":{"rendered":"Pipeline Update: Get in Shape, Fitness companies set terms for IPO"},"content":{"rendered":"

TERMS ADDED:<\/strong> <\/span><\/p>\n

Company: IsoPlexis Corporation
\nSymbol: ISO (Nasdaq)
\nDescription: They are enabling deeper access to in vivo biology and driving durable and potentially transformational research on disease in a new era of advanced medicine.
\nShares: 8.33 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $544m-$622m
\nTrade Date: Friday, 10\/8
\nUnderwriters: Morgan Stanley, Cowen, Evercore, SVB Leerink
\nLink to Prospectus: Terms Added: 10-1-21<\/p>\n

Company: Theseus Pharmaceuticals, Inc.
\nSymbol: THRX (Nasdaq)
\nDescription: They are a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies.
\nShares: 8.33 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $502m-$574m
\nTrade Date: Thursday, 10\/7
\nUnderwriters: Jefferies, SVB Leerink, Cantor
\nCo-Manager(s): Wedbush PacGrow
\nLink to Prospectus: Terms Added: 9-30-21<\/p>\n

Company: Cingulate, Inc.
\nSymbol: CING (Nasdaq)
\nDescription: They are a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
\nShares: 4.54 million
\nPrice Range: $10.00-$12.00
\nMarket Cap: $204m-$246m
\nTrade Date: Thursday, 10\/7
\nUnderwriters: Oppenheimer
\nCo-Manager(s): Ladenburg Thalmann, Brookline Capital
\nLink to Prospectus: Terms Added: 9-27-21<\/p>\n

Company: Life Time Group Holdings, Inc.
\nSymbol: LTH (NYSE)
\nDescription: They are a leading lifestyle brand offering premium health, fitness and wellness experiences to a community of nearly 1.4 million individual members, who together comprise more than 767,000 memberships, as of July 31, 2021.
\nShares: 46.2 million
\nPrice Range: $18.00-$21.00
\nMarket Cap: $3.6b-$4.15b
\nTrade Date: Thursday, 10\/7
\nUnderwriters: Goldman Sachs, Morgan Stanley, BofA Securities, Deutsche Bank, JP Morgan, Wells Fargo SEcurities, BMO Capital, Mizuho Securities, RBC Capital
\nCo-Manager(s): Guggenheim, Oppenheimer, BTIG< TPG Capital BD
\nLink to Prospectus: Terms Added: 9-29-21<\/p>\n

Company: iFIT Health & Fitness Inc
\nSymbol: IFIT
\nDescription: They are a health and fitness subscription technology company, fueled by our passion to innovate, grow and provide meaningful solutions for our members. iFIT is an integrated health and fitness platform, designed to connect our proprietary software, experiential content and interactive hardware to deliver an unmatched connected fitness experience.
\nShares: 30.8 million
\nPrice Range: $18.00-$21.00
\nMarket Cap: $5.7b-$6.6b
\nTrade Date: Wednesday, 10\/6
\nUnderwriters: Morgan Stanley, BofA Securities, Barclays, Citigroup, Credit Suisse, Jefferies, Baird
\nCo-Manager(s): Cowen, JMP Securities, Raymond James, Truist Securities, William Blair, Telsey Advisory Group
\nLink to Prospectus: Terms Added: 9-27-21<\/p>\n

 <\/p>\n

NEW FILINGS<\/strong><\/span><\/p>\n

Company: Ventyx Biosciences, Inc.
\nSymbol: VTYX (Nasdaq)
\nDescription: They are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Jefferies, Evercore ISI, Piper Sandler
\nCo-Manager(s): LifeSci Capital
\nLink to Prospectus: Filed: 9-29-21
\nListed Cash Raise: $100m<\/p>\n

Company: Ensemble Health Partners, Inc.
\nSymbol: ENSB (Nasdaq)
\nDescription: Ensemble Health Partners is a leading provider of technology-enabled revenue cycle management (\u201cRCM\u201d) solutions for health systems, including hospitals and affiliated physician groups.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Goldman Sachs, BofA Securities, Deutsche Bank, Guggenheim Securities, Credit Suisse, Evercore ISI, Wells Fargo Securities, SVB Leerink
\nCo-Manager(s): Baird, William Blair, Academy Securities, Loop Capital Markets
\nLink to Prospectus: Filed: 9-29-21
\nListed Cash Raise: $100m<\/p>\n

Company: Hexion Holdings Corporation
\nSymbol: HXN (NYSE)
\nDescription: They are a leading global producer of adhesives and performance materials that enable the production of engineered wood products, one of the world\u2019s most sustainable building products and other growing specialty materials.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Morgan Stanley
\nLink to Prospectus: Filed: 9-29-21
\nListed Cash Raise: $100m<\/p>\n

Company: Claire\u2019s Inc. .
\nSymbol: CLRS (Nasdaq)
\nDescription: They are a fully integrated global fashion brand powerhouse committed to inspiring self-expression through the creation and delivery of exclusive, well-curated products and experiences.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Goldman Sachs, Citigroup, Morgan Stanley, Cowen, Guggenheim Securities, Telsey Advisory Group
\nCo-Manager(s): Siebert Williams Shank
\nLink to Prospectus: Filed: 9-29-21
\nListed Cash Raise: $100m<\/p>\n

Company: Fluence Energy, Inc.
\nSymbol: FLNC (Nasdaq)
\nDescription: They are enabling the global clean energy transition with market-leading energy storage products and services and digital applications for renewables and storage.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: J.P. Morgan, Morgan Stanley, Barclays, BofA Securities, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, HSBC, RBC Capital
\nCo-Manager(s): Nomura, Baird, Raymond James, Seaport Global Penserra Securities LLC, Siebert Williams Shank
\nLink to Prospectus: Filed: 9-28-21
\nListed Cash Raise: $100m<\/p>\n

Company: Minerva Surgical, Inc
\nSymbol:UTRS (Nasdaq)
\nDescription: They are a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: J.P. Morgan, Piper Sandler, UBS Investment Bank, SVB Leerink
\nLink to Prospectus: Filed: 9-27-21
\nListed Cash Raise: $100m<\/p>\n

Company: Winc, Inc.
\nSymbol:BEV (NYSE)
\nDescription: They are one of the fastest growing at scale wineries in the United States.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: BofA Securities, Canaccord Genuity, Craig-Hallum, Roth Capital
\nCo-Manager: Benchmark Company
\nLink to Prospectus: Filed: 9-27-21
\nListed Cash Raise: $100m<\/p>\n

Company: The Vita Coco Company, Inc.
\nSymbol:COCO (Nasdaq)
\nDescription: They are a leading fast-growing, plant-based functional hydration platform, which pioneered packaged coconut water in 2004, and recently began extending into other healthy hydration categories.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters:Goldman Sachs, BofA Securities, Credit Suisse, Evercore ISI, Wells Fargo Securities, Guggenheim Securities, Piper Sandler, William Blair
\nLink to Prospectus: Filed: 9-27-21
\nListed Cash Raise: $100m<\/p>\n

Company: P10, Inc.
\nSymbol: PX (NYSE)
\nDescription: They are a leading multi-asset class private market solutions provider in the alternative asset management industry.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Morgan Stanley, J.P. Morgan, Barclays
\nCo-Manager(s): UBS Investment Bank, Keefe Bruyette & Woods, Oppenheimer & Co., Stephens Inc.
\nLink to Prospectus: Filed: 9-27-21
\nListed Cash Raise: $100m<\/p>\n

Company: Portillo\u2019s Inc.
\nSymbol: PTLO (Nasdaq)
\nDescription: Portillo\u2019s serves iconic Chicago street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Jefferies, Morgan Stanley, BofA Securities, Piper Sandler, Baird, UBS Investment Bank, William Blair
\nCo-Manager(s): Guggenheim Securities, Stifel, Loop Capital, Ramirez & Co.
\nLink to Prospectus: Filed: 9-27-21
\nListed Cash Raise: $100m<\/p>\n

Company: Paragon 28, Inc.
\nSymbol: FNA (NYSE)
\nDescription: They are a leading medical device company exclusively focused on the foot and ankle orthopedic market and we are dedicated to improving patient lives.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: BofA Securities, Piper Sandler
\nCo-Manager(s): Canaccord Genuity, JMP Securities, Needham & Co.
\nLink to Prospectus: Filed: 9-24-21
\nListed Cash Raise: $100m<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-21913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=21913"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21913\/revisions"}],"predecessor-version":[{"id":21914,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21913\/revisions\/21914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=21913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=21913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=21913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}